Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene:: Effect on the CYP1A2 inducibility in humans

被引:280
作者
Nakajima, M
Yokoi, T
Mizutani, M
Kinoshita, M
Funayama, M
Kamataki, T [1 ]
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Drug Metab, Sapporo, Hokkaido 0600812, Japan
[2] Otsuka Pharmaceut Co Ltd, Otsuka Assay Labs, Tokushima 7710130, Japan
[3] Sapporo Med Univ, Dept Legal Med, Sapporo, Hokkaido 0600812, Japan
关键词
caffeine metabolism; cigarette smoking; induction; PCR-RFLP;
D O I
10.1093/oxfordjournals.jbchem.a022352
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A genetic polymorphism was identified in the 5'-flanking region of human CYP1A2 gene, and its effect on the transcriptional activation of the CYP1A2 gene was investigated. Nucleotide sequence analysis revealed the existence of a point mutation from guanine (wild type) to adenine (mutated type) at position -2964 in the gene. This point mutation was detected by a polymerase chain reaction-restriction fragment length polymorphism method using DdeI or BslI restriction enzyme, and was proven to be genetically inherited. Allele frequency in 116 Japanese subjects showed 0.77 and 0.23 for the wild and mutated types of allele, respectively. The point mutation caused a significant decrease of CYP1A2 activity measured by the rate of caffeine 3-demethylation in Japanese smokers (p < 0.05), Gel retardation analysis showed the existence of protein bound to the polymorphic locus. These results suggest that this polymorphism is a causal factor of decreased CYP1A2 inducibility.
引用
收藏
页码:803 / 808
页数:6
相关论文
共 32 条
[1]   INTRAINDIVIDUAL VARIATION IN DRUG DISPOSITION [J].
ALVARES, AP ;
KAPPAS, A ;
EISEMAN, JL ;
ANDERSON, KE ;
PANTUCK, CB ;
PANTUCK, EJ ;
HSIAO, KC ;
GARLAND, WA ;
CONNEY, AH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :407-419
[2]   HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM) [J].
BUTLER, MA ;
IWASAKI, M ;
GUENGERICH, FP ;
KADLUBAR, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7696-7700
[3]   DETERMINATION OF CYP1A2 AND NAT2 PHENOTYPES IN HUMAN-POPULATIONS BY ANALYSIS OF CAFFEINE URINARY METABOLITES [J].
BUTLER, MA ;
LANG, NP ;
YOUNG, JF ;
CAPORASO, NE ;
VINEIS, P ;
HAYES, RB ;
TEITEL, CH ;
MASSENGILL, JP ;
LAWSEN, MF ;
KADLUBAR, FF .
PHARMACOGENETICS, 1992, 2 (03) :116-127
[4]  
BUTLER MA, 1989, CANCER RES, V49, P25
[5]   Human cytochrome P450 2E1 (CYP2E1): From genotype to phenotype [J].
Carriere, V ;
Berthou, F ;
Baird, S ;
Belloc, C ;
Beaune, P ;
deWaziers, I .
PHARMACOGENETICS, 1996, 6 (03) :203-211
[6]   Identification of positive and negative regulatory elements of the human cytochrome P4501A2 (CYP1A2) gene [J].
Chung, IJ ;
Bresnick, E .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 338 (02) :220-226
[7]   TISSUE-SPECIFIC INVITRO TRANSCRIPTION FROM THE MOUSE ALBUMIN PROMOTER [J].
GORSKI, K ;
CARNEIRO, M ;
SCHIBLER, U .
CELL, 1986, 47 (05) :767-776
[8]   OXIDATION OF TOXIC AND CARCINOGENIC CHEMICALS BY HUMAN CYTOCHROME-P-450 ENZYMES [J].
GUENGERICH, FP ;
SHIMADA, T .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (04) :391-407
[9]  
HAMMONS GJ, 1985, CANCER RES, V45, P3578
[10]   GENETIC POLYMORPHISMS IN THE 5'-FLANKING REGION CHANGE TRANSCRIPTIONAL REGULATION OF THE HUMAN CYTOCHROME P450IIE1 GENE [J].
HAYASHI, S ;
WATANABE, J ;
KAWAJIRI, K .
JOURNAL OF BIOCHEMISTRY, 1991, 110 (04) :559-565